31


MICROLUTETM y


PLR


Next Gener ation P hospholipid R emo v al


Go with the flow with a new innovative hybrid technology for phospholipid removal.


High Reproducibility Maximum Analyte Recovery Greater Sensitivity


Find out more at www.microplates.com/microlute


Robust and Reproducible IEX Columns


IEX is a widely used standard in Bio QC, especially of monoclonal antibodies. However, one of the crucial requirements for any QC method is a reliable lot-to-lot reproducibility. Unlike many other IEX columns on the market including widely used ‘standard’ ones, YMC’s BioPro IEX columns provide excellent lot-to-lot reproducibility together with superior


resolution. These features make them a first choice for Bio QC!


YMC’s BioPro IEX columns are specifically designed for separation of antibodies, proteins, peptides, nucleic acids and oligonucleotides showing higher binding capacity and recovery of biomolecules compared to conventional IEX columns. BioPro IEX columns are based on porous or non-porous hydrophilic polymer beads with low nonspecific adsorption.


YMC’s BioPro IEX columns are available either as a porous or a non-porous version. The 5 µm porous materials offer exceptionally high efficiency and low operating pressure, whilst the 3 or 5 µm non-porous particles provide high efficiency, very high resolution and low operating pressures as well.


The non-porous BioPro IEX SF columns with strong CEX functionality are especially useful for the analysis of antibodies and can also replace weak exchangers. By substituting these columns, it is possible to achieve a better analysis in a shorter time.


More information online: ilmt.co/PL/QDmx


Page 1  |  Page 2  |  Page 3  |  Page 4  |  Page 5  |  Page 6  |  Page 7  |  Page 8  |  Page 9  |  Page 10  |  Page 11  |  Page 12  |  Page 13  |  Page 14  |  Page 15  |  Page 16  |  Page 17  |  Page 18  |  Page 19  |  Page 20  |  Page 21  |  Page 22  |  Page 23  |  Page 24  |  Page 25  |  Page 26  |  Page 27  |  Page 28  |  Page 29  |  Page 30  |  Page 31  |  Page 32  |  Page 33  |  Page 34  |  Page 35  |  Page 36  |  Page 37  |  Page 38  |  Page 39  |  Page 40  |  Page 41  |  Page 42  |  Page 43  |  Page 44  |  Page 45  |  Page 46  |  Page 47  |  Page 48  |  Page 49  |  Page 50  |  Page 51  |  Page 52  |  Page 53  |  Page 54  |  Page 55  |  Page 56